Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes
- PMID: 25758940
- DOI: 10.1007/s00401-015-1406-3
Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes
Abstract
Multiple different pathological protein aggregates are frequently seen in human postmortem brains and hence mixed pathology is common. Mixed dementia on the other hand is less frequent and neuropathologically should only be diagnosed if criteria for more than one full blown disease are met. We quantitatively measured the amount of hyperphosphorylated microtubule associated tau (HP-τ), amyloid-β protein (Aβ) and α-synuclein (α-syn) in cases that were neuropathologically diagnosed as mixed Alzheimer's disease (AD) and neocortical Lewy body disease (LBD) but clinically presented either as dementia due to AD or LBD, the latter including dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD). Our study group consisted of 28 cases (mean age, 76.11 SE: ±1.29 years; m:f, 17:11) of which 19 were neuropathologically diagnosed as mixed AD/DLB. Clinically, 8 mixed AD/DLB cases were diagnosed as AD (cAD), 8 as DLB (cDLB) and 3 as PDD (cPDD). In addition, we investigated cases that were both clinically and neuropathologically diagnosed as either AD (pure AD; n = 5) or DLB/neocortical LBD (pure DLB; n = 4). Sections from neocortical, limbic and subcortical areas were stained with antibodies against HP-τ, Aβ and α-syn. The area covered by immunopositivity was measured using image analysis. cAD cases had higher HP-τ loads than both cDLB and cPDD and the distribution of HP-τ in cAD was similar to the one observed in pure AD whilst cDLB showed comparatively less hippocampal HP-τ load. cPDD cases showed lower HP-τ and Aβ loads and higher α-syn loads. Here, we show that in neuropathologically mixed AD/DLB cases both the amount and the topographical distribution of pathological protein aggregates differed between distinct clinical phenotypes. Large-scale clinicopathological correlative studies using a quantitative methodology are warranted to further elucidate the neuropathological correlate of clinical symptoms in cases with mixed pathology.
Similar articles
-
Patterns of tau, amyloid and synuclein pathology in ageing, Alzheimer's disease and synucleinopathies.Brain. 2025 May 13;148(5):1562-1576. doi: 10.1093/brain/awae372. Brain. 2025. PMID: 39531734 Free PMC article.
-
Neuroinflammation is associated with Alzheimer's disease co-pathology in dementia with Lewy bodies.Acta Neuropathol Commun. 2024 May 7;12(1):73. doi: 10.1186/s40478-024-01786-z. Acta Neuropathol Commun. 2024. PMID: 38715119 Free PMC article.
-
Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.Ann Neurol. 2019 Feb;85(2):259-271. doi: 10.1002/ana.25392. Epub 2019 Jan 7. Ann Neurol. 2019. PMID: 30549331 Free PMC article.
-
Prevalence and clinical associations of tau in Lewy body dementias: A systematic review and meta-analysis.Parkinsonism Relat Disord. 2020 Nov;80:184-193. doi: 10.1016/j.parkreldis.2020.09.030. Epub 2020 Sep 23. Parkinsonism Relat Disord. 2020. PMID: 33260030
-
Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.J Neural Transm (Vienna). 2018 Apr;125(4):615-650. doi: 10.1007/s00702-017-1821-9. Epub 2017 Dec 8. J Neural Transm (Vienna). 2018. PMID: 29222591 Review.
Cited by
-
Imaging Tau, Neuroinflammation, and Aβ in Dementia With Lewy Bodies: A Deep-Phenotyping Case Report.Mov Disord Clin Pract. 2018 Nov 8;6(1):77-80. doi: 10.1002/mdc3.12689. eCollection 2019 Jan. Mov Disord Clin Pract. 2018. PMID: 30746421 Free PMC article. No abstract available.
-
Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer's Disease Pathology.J Alzheimers Dis. 2021;80(3):1243-1256. doi: 10.3233/JAD-201187. J Alzheimers Dis. 2021. PMID: 33646154 Free PMC article.
-
The existence of Aβ strains and their potential for driving phenotypic heterogeneity in Alzheimer's disease.Acta Neuropathol. 2021 Jul;142(1):17-39. doi: 10.1007/s00401-020-02201-2. Epub 2020 Aug 2. Acta Neuropathol. 2021. PMID: 32743745 Review.
-
Effects of single and combined immunotherapy approach targeting amyloid β protein and α-synuclein in a dementia with Lewy bodies-like model.Alzheimers Dement. 2019 Sep;15(9):1133-1148. doi: 10.1016/j.jalz.2019.02.002. Epub 2019 Aug 1. Alzheimers Dement. 2019. PMID: 31378574 Free PMC article.
-
Are We Ready for Detecting α-Synuclein Prone to Aggregation in Patients? The Case of "Protein-Misfolding Cyclic Amplification" and "Real-Time Quaking-Induced Conversion" as Diagnostic Tools.Front Neurol. 2018 Jun 6;9:415. doi: 10.3389/fneur.2018.00415. eCollection 2018. Front Neurol. 2018. PMID: 29928254 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous